Greenwich LifeSciences, Inc. (GLSI) stock
GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$18.70+4.94 (+35.90%)
Close on Nov 17, 2026Market cap $274.48MP/E –Yield –
Greenwich LifeSciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for Greenwich LifeSciences
Greenwich LifeSciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?